Sanofi India · NSE: SANOFI · BSE: 500674
Q2 FY22 results · Jul–Sep 2021
Sanofi India reported revenue from operations of ₹754.50 crore (up 9.9% from Q2 FY21) and net profit of ₹529.80 crore (up 298.6% from Q2 FY21) for Q2 FY22 (Jul–Sep 2021), on a standalone basis.
| Item | Q2 FY22 | Q2 FY21 | YoY | Q1 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 754.50 | 686.60 | +9.9% | 789.10 | −4.4% |
| Other income | 14.70 | 14.90 | −1.3% | 17.10 | −14.0% |
| Total income | 769.20 | 701.50 | +9.7% | 806.20 | −4.6% |
| Profit before tax | 687.90 | 185.90 | +270.0% | 242.60 | +183.6% |
| Net profit for the period | 529.80 | 132.90 | +298.6% | 178.30 | +197.1% |
| EPS, basic (₹) | 230.04 | 57.71 | +298.6% | 77.42 | +197.1% |
| Net margin (%) | 70.2 | 19.4 | 22.6 |
Standalone
- Filed with BSE
- 27 Oct 2021, 13:13 IST
- Board meeting
- 26 Oct 2021
- Period
- 01 Jul 2021 to 30 Sep 2021
- Review status
- Unaudited
- Source
- XBRL filing on BSE